NCT04894747

Brief Summary

Dietary protein is vital for the preservation of health and optimal adaptation to training. Plant proteins are considered inferior to animal proteins with respect to their ability to stimulate an acute muscle building response and therefore support long-term muscle reconditioning. Pea protein is a highly commercially available plant proteins source (available as supplements, food ingredients etc.), yet there is no research investigating its ability to stimulate a muscle building response. The investigators aim to assess the effect of consuming pea protein on muscle protein synthesis rates and compare these results to mycoprotein, a source known to elicit a robust anabolic response. Pea protein is lower in some of the essential amino acids, namely methionine, which could mean it is less effective compared with mycoprotein which has a more complete amino acid profile. So in addition to comparing pea with mycoprotein, the investigators also want to compare to a blend of pea and mycoprotein to see if replenishing the amino acid content in pea 'rescues' the anabolic response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 20, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

March 22, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

May 5, 2021

Last Update Submit

March 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Muscle protein synthesis

    The rate of synthesis of new muscle protein (Fractional synthetic rate %/h)

    8.5 hours

Secondary Outcomes (4)

  • Plasma amino acid kinetics

    8.5 hours

  • Serum insulin concentrations

    8.5 hours

  • Translocation of mTOR via immunohistochemistry

    8.5 hours

  • mTOR phosphorylation via ATP kinase assay

    8.5 hours

Study Arms (3)

Mycoprotein

EXPERIMENTAL

Bolus ingestion of mycoprotein providing 25g of protein.

Dietary Supplement: Bolus ingestion of protein

Pea protein

EXPERIMENTAL

Bolus ingestion of pea protein providing 25g of protein.

Dietary Supplement: Bolus ingestion of protein

Mycoprotein/pea protein dry blend

EXPERIMENTAL

Bolus ingestion of mycoprotein/pea protein dry blend providing 25g of protein.

Dietary Supplement: Bolus ingestion of protein

Interventions

Bolus ingestion of proteinDIETARY_SUPPLEMENT

Ingestion of 25g of protein

Also known as: Protein ingestion
MycoproteinMycoprotein/pea protein dry blendPea protein

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI between 18 and 30
  • Resistance trained

You may not qualify if:

  • Any metabolic impairment
  • Smoking
  • Use of over the counter pharmaceuticals (excluding oral contraceptives and contraceptive devices).
  • A personal family history of epilepsy, seizures or schizophrenia.
  • Allergic to Quorn/mycoprotein/edible fungi/environmental mould products.
  • Any motor disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Exeter

Exeter, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2021

First Posted

May 20, 2021

Study Start

May 1, 2021

Primary Completion

June 15, 2022

Study Completion

June 15, 2022

Last Updated

March 22, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations